Clinical Trials Logo

Clinical Trial Summary

Context: Pituitary adenoma is generally indolent, but an aggressive subtype called atypical adenoma has uncertain prognosis, and an unclear relationship between prognosis and morphology.

Objective: This study investigated the prognostic factors of this tumor. Design: Retrospective analysis. Setting: University and associated hospitals.


Clinical Trial Description

n/a


Study Design

Observational Model: Case Control, Time Perspective: Cross-Sectional


Related Conditions & MeSH terms


NCT number NCT00473369
Study type Observational
Source Tohoku University
Contact
Status Active, not recruiting
Phase N/A
Start date January 2001
Completion date May 2007

See also
  Status Clinical Trial Phase
Recruiting NCT04897802 - Identification and Clinical Relevance of an Oxytocin Deficient State (GLP1 Study) Phase 4
Completed NCT03137615 - The Cardiovascular Changes Associated With Septal Local Anaesthesia N/A
Completed NCT03305016 - A Safety, Tolerability and Efficacy Study of TransCon hGH in Children With Growth Hormone Deficiency Phase 3
Completed NCT02084134 - Peri-Operative Steroid Management in Patients N/A
Completed NCT00234533 - Study to Define Optimal IGF-1 Monitoring in Children Treated With NutropinAq Phase 3
Completed NCT04902235 - Identification and Clinical Relevance of an Oxytocin Deficient State (CRH Study) Phase 4
Recruiting NCT04951557 - Setting Benchmarks for Transsphenoidal Resection of Pituitary Adenomas
Recruiting NCT06435195 - Clinical Characteristics and Analysis of Pituitary Complex and Rare Diseases
Active, not recruiting NCT03665064 - Long Term Outcome Study in Patients With Pituitary Disorders
Completed NCT02782208 - Lipolytic Effects of GH in Hypopituitary Patients in Vivo N/A
Recruiting NCT04326374 - Safety, Tolerability and Efficacy of TransCon hGH Weekly Versus Daily hGH in Chinese Pediatric Growth Hormone Deficiency Phase 3
Completed NCT03344458 - A Long-Term Trial Investigating Safety and Efficacy of TransCon hGH in Children With Growth Hormone Deficiency Who Have Completed a Prior TransCon hGH Clinical Trial Phase 3
Completed NCT02781727 - A Phase 3 Trial of the Safety, Tolerability and Efficacy of TransCon hGH Weekly Versus Daily hGH in Children With Growth Hormone Deficiency (GHD) Phase 3